BioMarin Pharmaceutical | BMRN - Capitalizzazione Di Mercato





Capitalizzazione Di Mercato Cambiamento Data
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.53B 57M 2026-04
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
Biogen USD 27.49B 589M 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 21.96B 3.23B 2026-04
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 10.55B 1.91B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.46B 6.22B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 117.34B 2.45B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12